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Recent data suggest that NETosis plays a crucial role in the innate immune response and 
disturbs the homeostasis of the immune system. NETosis is a form of neutrophil-specific 
cell death characterized by the release of large web-like structures referred to as neu-
trophil extracellular traps (NETs). NETs are composed of DNA strands associated with 
histones and decorated with about 20 different proteins, including neutrophil elastase, 
myeloperoxidase, cathepsin G, proteinase 3, high mobility group protein B1, and LL37. 
Reportedly, NETosis can be induced by several microbes, and particulate matter includ-
ing sterile stimuli, via distinct cellular mechanisms. Meanwhile, suicidal NETosis and vital 
NETosis are controversial. As we enter the second decade of research on NETosis, we 
have partly understood NETs as double-edged swords of innate immunity. In this review, 
we will discuss the mechanisms of NETosis, its antimicrobial action, and role in autoim-
mune diseases, as well as the relatively new field of NET-associated mitochondrial DNA.
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iNTRODUCTiON
Neutrophil granulocytes are the most abundant type of white blood cells in humans and play a vital 
role in innate immunity by defending the host against invading pathogens. The immune regula-
tory functions of neutrophils include phagocytosis, generation of reactive oxygen species (ROS), 
degranulation, and the formation of neutrophil extracellular traps (NETs), a process referred to as 
NETosis. NETosis is accepted as a specific form of cell death subroutine performed by granulocytes, 
differing from apoptosis and necrosis (1, 2). When neutrophils undergo NETosis, nuclear and 
granular membranes disintegrate, the chromatin decondenses, and it diffuses into the cytoplasm, 
mixing with cytoplasmic proteins. This is followed by plasma membrane rupture and the release 
of chromatin, decorated with granular proteins, into the extracellular space (2, 3). NETs consist of 
chromatin fibers with diameters of 15–17 nm that contain DNA and the histones H1, H2A, H2B, 
H3, and H4. Moreover, the DNA fibers are decorated with several proteins like neutrophil elastase 
(NE), myeloperoxidase (MPO), cathepsin G, proteinase 3 (PR3), high mobility group protein B1 
(HMGB1), and LL37, thus displaying proinflammatory characteristics (1). In the past decade, new 
aspects of neutrophil functions have emerged unveiling their significance not only in defending 
the host against microbes but also in contributing to many autoimmune pathological conditions. 
Therefore, the purpose of this review is to present and discuss the current knowledge about the 
mechanisms of NETosis and its role in the pathogenesis of autoimmune diseases.
FiGURe 1 | (i) Several stimuli (e.g., bacteria, viruses, fungi) initiate NeTosis by binding to neutrophil receptors (e.g., Fc receptors, TLRs), which activate 
the endoplasmic reticulum to release stored calcium ions. (II) Elevated cytoplasmic calcium levels increase PKC activity, which induces NADPH oxidase to 
assemble into a functional complex (PHOX). (III) Subsequently, PHOX (or alternatively the mitochondrial respiratory chain) generate ROS. (IV) ROS generation leads to 
the rupture of granules and the nuclear envelope. (V) Meanwhile, NE and MPO translocate to the nucleus. (VI) As a result, histone deimination and chromatin 
decondensation contribute to the formation of NETs. (VII) Finally, the rupture of the plasma membrane causes neutrophil lysis and allows the release of NETs.
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MeCHANiSMS OF NeTosis
Neutrophil suicide, distinct from either necrosis or apoptosis, 
was first described following chemical stimulation with phorbol 
12-myristate 13-acetate (PMA) in 1996 (4). This form of cell death 
was characterized by the disintegration of nuclear and granular 
membranes and by the release of decondensed chromatin into 
the cytoplasm. In 2004, Zychlinsky and colleagues reported 
that neutrophil suicide resulted in the release of large web-like 
structures composed of decondensed chromatin and neutrophil 
antimicrobial factors, and coined the name neutrophil extracel-
lular traps (1). In their studies, they used PMA and interleukin-8 
(IL-8) to elicit NETs in vitro. In 2007, it was reported that, going 
along with chromatin decondensation, neutrophils undergo 
an NADPH oxidase-dependent death process that includes 
nuclear envelope disintegration and the mixing of nucleic 
acids and granule proteins within a large intracellular vacuole 
(3). After the association of nucleic acids and granule proteins, 
NETs are released via plasma membrane perforation and cell 
lysis. This process is completed1–4 h after the inciting stimulus. 
The released chromatin structures are prone to bind particular 
matter, e.g., bacteria. The authors concluded that PMA-induced 
NETosis is a form of a beneficial suicide (3). Apart from PMA 
and IL-8, bacteria, fungi, protozoa, antibody–antigen complexes 
(5), autoantibodies (6), tumor necrosis factor (TNF), interferon 
(IFN) (7), and further stimuli also trigger NETosis.
PATHwAYS
Conventional suicidal NETosis has long been recognized as a 
distinct form of active cell death. In addition, some researchers 
have described a different mechanism by which NETs are formed, 
termed vital NETosis. This non-suicidal pathway allows NET 
release from neutrophils staying viable (8–12).
CONveNTiONAL SUiCiDAL NeTosis
Conventional suicidal NETosis is frequently initiated by ligand 
binding to neutrophil toll-like receptors and receptors for IgG–Fc, 
complement, or cytokines (1, 5, 13). Upon activation of these 
receptors, calcium storages of the endoplasmic reticulum release 
calcium ions into the cytoplasm. Elevated cytoplasmic calcium 
levels increase protein kinase C (PKC) activity and phosphoryla-
tion of gp91phox (14). This induces the assembly of the cytosolic 
and membrane-bound subunits of NADPH oxidase into func-
tional complexes at cytoplasmic or phagosomal membranes (also 
called phagocytic oxidase, PHOX) and the subsequent generation 
of ROS (15). Under the influence of ROS, granules and the nuclear 
envelope rupture. Subsequently, the released nuclear, granular, 
and cytoplasmic contents blend. NE and MPO, usually stored in 
azurophilic granules, migrate to the nucleus. Here, NE degrades 
the linker histone H1 and processes the core histones, and MPO 
enhances chromatin decondensation (15). Histone deimination 
by peptidyl arginine deiminase 4 (PAD4) and proteolytic cleav-
age of histones initiated before nuclear breakdown additionally 
contribute to chromatin decondensation (16, 17). The rupture of 
the plasma membrane allows the release of NETs and leads to cell 
death and the loss of viable cell functions of like migration and 
phagocytosis (Figure 1) (15).
ReACTive OXYGeN SPeCieS
The generally accepted notion that ROS play a crucial role in 
the classical suicidal NETosis pathway is based on two impor-
tant observations: (1) Neutrophils from patients with chronic 
granulomatous disease (CGD), not capable of performing the 
oxidative burst, show strongly reduced abilities to form NETs. 
This is independent of the type of mutation leading to a defec-
tive PHOX complex. CGD patients suffer from severe and often 
chronic infections (3, 18). Moreover, treatment with H2O2 res-
cued the production of NETs in neutrophils from CGD patients, 
downstream of the PHOX complex (3). (2) ROS scavengers, such 
as N-acetylcysteine, or trolox reportedly inhibit NETosis (3, 19). 
In fact, it remains unclear how ROS participate in the dismantling 
of the nuclear envelope or the mixing of the NET components. 
Some studies suggest that ROS directly promote the morphologic 
changes observed during NETosis (14). ROS may alternatively 
inactivate caspases, thereby inhibiting apoptosis and favoring 
FiGURe 2 | Some NeTosis-inducing stimuli involve TLR4 on platelets. Under these conditions, neutrophils release NETs via blebbing of the nuclear 
envelope and vesicular exportation. As a result, neutrophils become nuclear cytoplasts, which are still able to migrate and retain several conventional functions 
of viable neutrophil.
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autophagy. This leads to dissolution of cellular membranes (20). 
These two alternatives are not mutually exclusive: under certain 
experimental conditions, each of them can also act independently. 
There is now growing evidence that some stimuli induce NETosis 
independent of NADPH oxidase. Oxidant-independent release of 
NETs was studied in detail by Winterbourn and colleagues (21).
PePTiDYL ARGiNiNe DeiMiNASe 4
Peptidyl arginine deiminase 4 catalyzes the conversion of argi-
nine residues to citrullinein polypeptides, thereby eliminating 
a positive charge of the protein. Thus, citrullination of histones 
weakens the stability of nucleosomes (22, 23). Loss of positive 
charges causes the opening of the compact structure of chroma-
tin and allows decondensation and dispersion of chromatin in 
the form of NETs. Consistently, neutrophils from mice with a 
PAD4 deficiency display impaired capacities to form NETs and 
are highly susceptible to severe skin infections in vivo (16, 17). 
However, PAD4 deficiency does not contribute to lung infections 
caused by influenza virus (16).
viTAL NeTosis
Contrary to previous studies describing the canonical pathways 
of NETosis as a process requiring several hours, Clark et  al. 
reported in 2007 that lipopolysaccharide (LPS)-stimulated 
NETosis occurred within just 30 min involving TLR4 on platelets 
(8). It was demonstrated that neutrophils that released NETs 
remained impermeable for SYTOX Green, indicating that they 
remained structurally intact. Therefore, the authors later coined 
the term vital NETosis (12). Electron microscopy revealed that 
NET release induced by Staphylococcus aureus occurs via bleb-
bing of the nuclear envelope and vesicular exportation in vitro 
and in vivo (9). As a result, this pathway preserved the integrity 
of the neutrophils’ plasma membranes (Figure  2). NETting 
neutrophils became anuclear cytoplasts capable of chasing 
and imprisoning live Staphylococci (10). Candida albicans was 
reported a further stimulus of vital NETosis (11). It still remains 
controversial whether and how suicidal and vital NETosis coexist. 
Furthermore, it is not clear if a neutrophil that has ejected (parts 
of) its DNA should be termed “viable.”
MiTOCHONDRiAL DNA
As mentioned above, ROS are indispensable for several kinds 
of NETosis (24). In mammals, both the mitochondrial respira-
tion chain and the NADPH oxidase independently contribute 
to the production of ROS (25). Recently, it has been observed 
that in vivo inhibition of mitochondrial ROS production reduced 
intracellular ROS levels and NETosis (26). Ribonucleoprotein 
immune complexes (RNP ICs) were used to stimulate neutro-
phils and mitochondrial ROS generation. Mitochondria became 
hypopolarized, translocated to the cell surface, and were observed 
within the expelled NETs. Concomitantly, mitochondrial ROS 
oxidized mitochondrial DNA (mtDNA), which is proinflam-
matory in  vitro. When injected into mice, oxidized mtDNA 
triggered inflammation and type I IFN production via a pathway 
dependent on the DNA sensor STING (7, 26). Mitochondria have 
evolved from bacteria and contain unmethylated CpG motifs 
(27) as well as N-formylated peptides (28). Similar to bacteria, 
extracellular mitochondria are stimulators of proinflammatory 
signaling. Several reports attribute this effect to the unmethylated 
CpG DNA repeats within the mtDNA (29), others highlight the 
effect of DNA oxidation (28).
In patients with systemic lupus erythematosus (SLE), abnor-
mal NETosis and defects in the clearance of NETs were found 
to promote the production and release of type I IFN (30). In 
contrast, patients with CGD carry an increased risk to suffer 
from SLE, despite lacking functional NADPH oxidase activity 
(18), the major source of ROS in activated healthy neutrophils. 
Based on this observation, one might question whether increased 
NETosis is a factor contributing to the etiopathogenesis of SLE. 
TABLe 2 | Pathogens which evade entrapments via degrading NeTs.
Species Reference
V. cholera (51)
Streptococcus pneumoniae (52)
Streptococcus pyogenes (53)
Yersinia (54)
Streptococcus agalactiae (55)
Streptococcus suis (56)
Staphylococcus aureus (57)
Aeromonas hydrophila (58)
TABLe 1 | Pathogens that induce NeTs.
Species Reference
Staphylococcus aureus (9, 35)
Streptococcus sp. (36)
Haemophilus influenzae (37)
Klebsiella pneumoniae (15)
Listeria monocytogenes (38)
Mycobacterium tuberculosis (39)
Shigella flexneri (1)
Aspergillus nidulans (40)
Aspergillus fumigatus (41)
Candida albicans (42)
Yersinia (1)
Porphyromonas gingivalis (43)
V. cholera (51)
Aeromonas hydrophila (58)
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Instead, deficiency of the clearance of NETs is likely to foster the 
antinuclear autoimmunity in patients with SLE (30, 31). However, 
Kaplan and colleagues reexamined the importance of ROS in 
low-density granulocytes from patients with CGD and observed 
that this granulocyte subpopulation undergoes spontaneous 
NETosis and that their mitochondrial respiration produces suf-
ficient amounts of ROS to execute NETosis. The levels of ROS 
derived from low-density granulocytes correlated with the levels 
of type I IFN in the corresponding patients. Accordingly, the 
authors not only confirmed that mitochondria drove NETosis 
but also concluded that NETosis is a pathological factor able to 
foster SLE (26, 32). Consistently, anti-mtDNA antibodies were 
elevated in the sera of patients with SLE, and antibody levels cor-
related with IFN scores and disease activity. Immune complexes 
containing mtDNA induced more IFN-α than those with nuclear 
dsDNA. Thus, anti-mtDNA antibodies can be considered as 
typical for driving both SLE and lupus nephritis (33). As a drug 
that selectivity inhibits mitochondrial respiratory chain complex 
I and decreases NADPH oxidase activity (34), metformin may be 
a new option to treat SLE (33).
ANTiMiCROBiALS
Numerous microbes reportedly induce formation of NETs 
(Table  1). NET-inducing molecules include the bacterial cell 
surface components LPS, lipoteichoic acid, and their breakdown 
products. Several bacteria and fungi were reported to potently 
induce NET formation, such as Staphylococcus aureus (9, 35), 
Streptococcus sp. (36), Haemophilus influenzae (37), Klebsiella 
pneumonia (15), Listeria monocytogenes (38), Mycobacterium 
tuberculosis (39), Shigella flexneri (1), Aspergillus nidulans, 
Aspergillus fumigatus, and Candida albicans (40–42). Further 
examples are pathogens, such as Yersinia (1) and members of the 
oral microbiome, including Porphyromonas gingivalis (43). NETs 
can immobilize and kill a broad range of microbes, including 
bacteria, fungi, and protozoa (1, 9, 15, 35–42), and thus prevent 
the dissemination of microbial pathogens (37). Some studies 
have questioned the killing capabilities of NETs since viable 
Staphylococcus aureus and Candida albicans blastospores were 
released from NETs by incubation with DNases (44). Branzk 
et al. found that in response to large pathogens, like filamentous 
Candida albicans, neutrophils selectively released NETs (45). 
Intriguingly, NETosis did not occur in response to the yeast form 
of Candida albicans or single bacteria. Phagocytosis via dectin-1 
acted as a sensor of microbial size and prevented NET release by 
downregulating translocation of NE to the nucleus. Apart from 
directly killing microbes, NETs inactivate microbial “virulence 
factors” that alter the function of host cells. NET-associated 
NE specifically cleaved virulence factors of Shigella flexneri, 
Salmonella typhimurium, and Yersinia enterocolitica (1). The 
serine proteases cathepsin G and PR3 may also destroy virulence 
factors of further classes of microbes (46). NETs contain several 
proteins that inhibit microbes, including enzymes, antimicrobial 
peptides, calgranulin, and histones. The microbicidal activity of 
NETs results from the combined action of several components 
being enhanced by the high local concentrations of mediators on 
the NETs’ surfaces (15).
Various components of NETs contribute to different aspects 
of microbicidal activity. It was shown that the activity of MPO 
on NETs is essential to eliminate S. aureus (47). The antifungal 
activity of NETs has been assigned to calgranulin (48), which 
chelates zinc, a cation required for fungal growth (15). Also, 
histones restrict microbial growth very efficiently, and antibodies 
against histones prevent NET-mediated microbicidal activity (1). 
Microbes are suggested to be entrapped due to electrostatic inter-
actions between the positively charged bacterial surface and the 
negatively charged chromatin fibers based on electrostatic inter-
actions (49). Encapsulated pathogens or those that can change 
their surface charge may escape entrapment (50). Importantly, 
several bacteria are able to degrade NETs by nucleases and thus 
escape NET-mediated entrapment (Table 2). These include the 
Gram-negative pathogen Vibrium cholera (51) and the Gram-
positive bacteria Streptococcus pneumoniae (52), Streptococcus 
pyogenes (53), Yersinia ssp. (54), Streptococcus agalactiae (55), 
Streptococcus suis (56), Staphylococcus aureus (57), and Aeromonas 
hydrophila (58). This emphasizes the importance of nucleases as 
pathogenic factors.
THe ROLe OF NeTosis iN AUTOiMMUNe 
DiSeASeS
vasculitis
Vasculitis manifests in vessel wall inflammation and can affect any 
organ system of the body. ANCA-associated vasculitis (AAV), a 
subgroup of the vasculitides, is characterized by involvement of 
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the small vessels, a neutrophil-rich necrotizing inflammation, 
and the presence of anti-neutrophil cytoplasmic antibodies 
(ANCAs) (59). AAV comprises granulomatosis with polyangiitis 
(formerly Wegener’s granulomatosis), microscopic polyangiitis, 
and eosinophilic granulomatosis with polyangiitis (formerly 
Churg–Strauss syndrome). Many ANCAs are directed against 
PR3 or MPO, enzymes typically found in the azurophilic gran-
ules of neutrophils and on the surfaces of NETs (60). NETs are 
reportedly released by ANCA-stimulated neutrophils and in turn 
contain the autoantigens PR3 and MPO (39). This suggests that 
NET formation triggers vasculitis and promotes the autoimmune 
response against neutrophil components in individuals with 
small-vessel vasculitis (61). Consistently, increased levels of NET 
remnants containing complexes of nucleosomes and MPO have 
been detected in the circulation of patients with active vasculitis 
(39) and in patients with active AAV (60). Neutrophils of patients 
with AAV exhibited an increased tendency for spontaneous cell 
death. The levels of NET remnants were positively correlated with 
disease activity and neutrophil count, but inversely with ANCA 
at least during remission.
Systemic Lupus erythematosus
Systemic lupus erythematosus is a complex multifactorial auto-
immune disease associated with severe organ damage. NETs are 
considered a potential source of autoantigens. Polymorphonuclear 
leukocytes (PMNs) of patients with SLE display an increased 
propensity to execute NETosis in conjunction with impaired 
degradation of NETs by circulating DNase1. The aberrant NETs 
induce type I IFN, which is associated with vascular complica-
tions and tissue damage (30, 62).
High numbers of low-density granulocytes have been 
identified as a particular subset of neutrophils in SLE patients. 
Low-density granulocytes persistently produced TNF and type 1 
IFN, and spontaneously underwent NETosis (24). Furthermore, 
increased IFN-α in SLE patients is an important driving force that 
primes neutrophils for the execution of NETosis (63).
Not only production but also degradation of NETs is altered 
in SLE patients. Sera of a subgroup of SLE patients degrade NETs 
less efficiently than those of healthy controls (30). The deficient 
clearance of NETs in patients with SLE correlates with high titers 
of anti-NET antibodies and renal involvement (30). In healthy 
individuals, mononuclear phagocytes clear NETs in cooperation 
with DNase1 and C1q both synergizing in predigesting the chro-
matin part (64). The activities of serum DNase1 in patients with 
SLE are lower than that of healthy controls (65). Increased serum 
levels of DNase1 inhibitors, rare mutations in the gene of DNase1, 
and anti-DNase 1 antibodies may explain the decreased activity of 
DNase 1 (66, 67). Circulating chromatin in the form of immune 
complexes in individuals with SLE contains LL37, which triggers 
TLR9 in plasmacytoid dendritic cells, induces IFN-α synthesis, 
and protects nucleic acids from degradation by nucleases (68, 69). 
A study found that the individual NET degradation activity in the 
circulation of a given patient changed with disease activity. Sera of 
patients with SLE, which were not able to degrade NETs, showed 
increased complement consumption, since NETs activate the 
classical complement pathway due to their interaction with C1q 
(70). Thus, strategies that eliminate NETs and their components 
from the circulation pose a promising therapeutic approach for 
the treatment of patients with SLE (70).
Thrombosis
Neutrophil extracellular traps promote thrombosis by providing 
a scaffold and stimulus for platelet and red blood cell adhe-
sion and aggregation (71), thus enhancing coagulation (72). 
Neutrophils in thrombi are required for propagation of deep 
venous thromboses by binding factor XII and supporting its 
activation through NETosis (73). The major components of 
NETs (DNA, histones, and proteases) all display procoagulant 
properties. DNA induces thrombin generation in plasma and 
increases the protease activity of coagulation factors (74, 75). 
Histones may directly induce epithelial and endothelial cell 
death (76), and can mediate thrombosis in vivo (77). Histones 
were found to inhibit anticoagulation of plasma by promoting 
thrombin generation and hamper thrombomodulin function 
(78, 79). Elastase inactivated the tissue factor pathway inhibitor; 
thus, further increasing coagulation and fibrin deposition in vivo 
(72). Release of NETs in the vascular compartment triggered a 
procoagulant state and promoted binding and activation of 
platelets leading to thrombosis (80).
Rheumatoid Arthritis
In the autoimmune disease, rheumatoid arthritis (RA), the forma-
tion of autoantibodies to citrullinated proteins (ACPA) is thought 
to be a key pathogenic factor. Given that histone citrullination is 
implicated in NET formation, NETosis may play a critical role in 
RA (81). In 2013, Kaplan and colleagues found that neutrophils 
from patients with RA had a greater tendency to release NETs 
than neutrophils from healthy controls. RA serum and synovial 
fluid was a strong inducer of NETosis (82). Furthermore, NETosis 
resulted in the externalization of citrullinated protein antigens 
and immune-stimulatory molecules that may promote aberrant 
adaptive and innate immune responses in the joint.
Diabetes
Diabetes mellitus (or diabetes) is a chronic, lifelong condition, 
in which impaired insulin secretion and variable degrees of 
peripheral insulin resistance lead to hyperglycemia and affect 
the body’s ability to use food energy. Under conditions of hyper-
glycemia, neutrophils reportedly produce more superoxide and 
cytokines, like TNF-α, which triggers NETosis (83, 84). Based 
on these studies, we speculated that hyperglycemia may facilitate 
NETosis. Recently, Wong et al. (85) isolated neutrophils from type 
1 and type 2 diabetic humans and mice. Nearly twice as many 
neutrophils derived from patients released NETs in comparison 
to cells from healthy controls. The authors attributed this to PAD4 
and revealed a fourfold upregulation of PAD4 protein expression 
in the neutrophils from individuals with diabetes as compared to 
healthy controls. It is well established that delayed wound healing 
is a hallmark of patients with diabetes. The authors reported that 
large quantities of NETs were found in excisional skin wounds of 
diabetic mice and that DNase1, which dismantled NETs, acceler-
ated wound healing. Despite the triggers of NETosis in wounds 
remaining elusive, it has been confirmed that inhibiting NETosis 
or degrading NETs improved wound healing and reduced 
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NET-driven chronic inflammation in diabetes (85). However, the 
exact role of NETosis in wound healing remains to be revealed.
Cancer
NETosis may influence tumor development during many stages, 
including growth, angiogenesis, and metastasis. It has been 
observed that there is a large necrotic area of dead neutrophils 
and NET-like structures in Lewis lung carcinoma and Ewing 
sarcoma (86, 87). It remains to be clarified whether these NETs are 
responsible for the generation of the necrotic areas. Alternatively, 
NETs may serve to shield healthy tissues from necrotic areas. 
A study observed NET deposition on the microvasculature and 
subsequent local trapping of circulating cancer cells. The tumor 
cells, immobilized by NETs, survived and proliferated to form nod-
ules. This suggests a role for NETs in enhancing tumor metastasis 
(88). However, whether NETs just protect or anchor cancer cells 
physically or whether they promote tumor growth is still elusive.
Sepsis
The pathology of sepsis results from infection, hyperinflamma-
tory host response, and immune paralysis. During sepsis, NETs 
are released in the vascular system, where they trap bacteria 
(8, 12). Trapped bacteria can be killed, protecting patients from 
bacterial overflow (1, 44). In contrast, NET deposition in organs 
and their pro-thrombotic activities may also contribute to organ 
failure (89, 90). When researchers subjected mice to polymicro-
bial sepsis following cecal ligation and puncture, PAD4-deficient 
mice showed a similar survival rate when compared to wild-type 
controls (91). However, PAD4-deficient mice were partially 
protected from LPS-induced shock, indicating that NETs may 
contribute to the toxic inflammatory and procoagulant host 
response to bacteria in sepsis. The authors proposed that pre-
venting NET formation by PAD4 inhibition in inflammatory or 
thrombotic diseases is not likely to increase host vulnerability to 
bacterial infections (91).
CONCLUSiON
Progress in the research on NETosis has greatly increased our 
understanding of its role in immunological processes and 
autoimmune disorders. Recent studies described how autoanti-
gens, released during NETosis, activate immune cells and that 
cytokines in turn give rise to further NETosis. Aggregated NETs 
finally sequester and degrade proinflammatory mediators to 
avoid excessive inflammation (8, 14). The published data also 
revealed that blocking the process of NETosis or inhibiting the 
activity of components in NETs might be effective in the treat-
ment of autoimmune diseases. Future work investigating the 
exact process of NETosis and the interplay of NET components 
and the immune system will contribute to a deeper understand-
ing of the role of neutrophils in the induction and resolution of 
inflammation.
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